Page last updated: 2024-09-04

docetaxel anhydrous and Carcinoma, Adenoid Cystic

docetaxel anhydrous has been researched along with Carcinoma, Adenoid Cystic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Ahn, MJ; Chung, MK; Jeong, HS; Jung, HA; Kim, HR; Lee, SH; Lee, SJ; Park, S	1
Fouret, P; Handra-Luca, A; Planchard, D	1
Adachi, M; Fujimoto, Y; Hagiwara, S; Lai, SY; Mitsudo, K; Shigetomi, T; Tohnai, I; Yamamoto, N	1
Bauduceau, O; Bernard, O; Ceccaldi, B; Dourhte, LM; Hervé, R; Le Moulec, S	1
Hatayama, Y; Kakehata, S; Maruya, S; Matsubara, A; Nagahata, M; Namba, A; Shinkawa, H; Shirasaki, T; Takeda, I; Yokoyama, J	1

Trials

1 trial(s) available for docetaxel anhydrous and Carcinoma, Adenoid Cystic

Article	Year
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer. Cancer research and treatment, 2022, Volume: 54, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Ductal; Cisplatin; Docetaxel; Humans; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salivary Gland Neoplasms; Treatment Outcome	2022

Article

Year

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.

Cancer research and treatment, 2022, Volume: 54, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Ductal; Cisplatin; Docetaxel; Humans; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salivary Gland Neoplasms; Treatment Outcome

2022

Other Studies

4 other study(ies) available for docetaxel anhydrous and Carcinoma, Adenoid Cystic

Article	Year
Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation. Oral oncology, 2009, Volume: 45, Issue:11 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Magnetic Resonance Imaging; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Taxoids; Tomography, X-Ray Computed	2009
Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery. Head & neck, 2013, Volume: 35, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus Neoplasms; Middle Aged; Taxoids; Temporal Arteries; Treatment Outcome	2013
[Cylindroma of the trachea, a rate tumor with unusual evolution]. Presse medicale (Paris, France : 1983), 2003, Apr-05, Volume: 32, Issue:13 Pt 1 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Paclitaxel; Radiography, Thoracic; Radiotherapy Dosage; Taxoids; Tracheal Neoplasms; Treatment Outcome	2003
Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel. International journal of clinical oncology, 2006, Volume: 11, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Parotid Neoplasms; Radiotherapy, Adjuvant; Sublingual Gland Neoplasms; Taxoids; Treatment Outcome	2006